Recursion Pharmaceuticals (RXRX) shares soared 5.8% in the last trading session to close at $5.84. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 8% gain over the past four weeks.The sudden soaring of the stock price can be attributed to the postive investor mindset regarding the potential of Recursion's early-stage oncology pipeline being developed using its AI-driven platform technology. This biotechnology company is expected ...